The	DT
JAK2	NN
pathway	NN
is	VBZ
activated	VBN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
the	DT
most	RBS
rapidly	RB
progressive	JJ
and	CC
fatal	JJ
fibrotic	JJ
disorder	NN
,	,
with	IN
no	DT
curative	JJ
therapies	NNS
.	.

The	DT
signal-transducer-and-activator-of-transcription-3	NN
(	(
STAT3	NN
)	)
protein	NN
is	VBZ
activated	VBN
in	IN
lung	NN
fibroblasts	NNS
and	CC
alveolar	JJ
type	NN
II	CD
cells	NNS
(	(
ATII	NN
)	)
,	,
thereby	RB
contributing	VBG
to	TO
lung	NN
fibrosis	NN
in	IN
IPF	NN
.	.

Although	IN
activation	NN
of	IN
Janus-kinase-2	NN
(	(
JAK2	NN
)	)
has	VBZ
been	VBN
implicated	VBN
in	IN
proliferative	JJ
disorders	NNS
,	,
its	PRP$
role	NN
in	IN
IPF	NN
is	VBZ
unknown	JJ
.	.

The	DT
aim	NN
of	IN
this	DT
study	NN
was	VBD
to	TO
analyze	VB
JAK2	NN
activation	NN
in	IN
IPF	NN
,	,
and	CC
to	TO
determine	VB
whether	IN
JAK2/STAT3	NN
inhibition	NN
is	VBZ
a	DT
potential	JJ
therapeutic	JJ
strategy	NN
for	IN
this	DT
disease	NN
.	.

METHODS	NNS
AND	CC
RESULTS	NNS
:	:
JAK2/p-JAK	NN
2	CD
and	CC
STAT3/pSTAT3	NN
expression	NN
was	VBD
evaluated	VBN
using	VBG
quantitative	JJ
real	JJ
time-PCR	NN
,	,
western	NN
blotting	NN
,	,
and	CC
immunohistochemistry	NN
.	.

Compared	VBN
to	TO
human	JJ
healthy	JJ
lung	NN
tissue	NN
(	(
n	NN
=	JJ
10	CD
)	)
both	DT
proteins	NNS
were	VBD
upregulated	VBN
in	IN
the	DT
lung	NN
tissue	NN
of	IN
IPF	NN
patients	NNS
(	(
n	NN
=	JJ
12	CD
)	)
.	.

Stimulating	VBG
primary	JJ
ATII	NN
and	CC
lung	NN
fibroblasts	NNS
with	IN
transforming-growth-factor-beta-1	NN
or	CC
interleukin	NN
(	(
IL	NN
)	)
-6	CD
/	:
IL-13	NN
activated	VBD
JAK2	NN
and	CC
STAT3	NN
,	,
inducing	VBG
epithelial	JJ
to	TO
mesenchymal	JJ
and	CC
fibroblast	NN
to	TO
myofibroblast	NN
transitions	NNS
.	.

Dual	JJ
p-JAK2	NN
/	:
p-STAT3	NN
inhibition	NN
with	IN
JSI-124	NN
or	CC
silencing	NN
of	IN
JAK2	NN
and	CC
STAT3	NN
genes	NNS
suppressed	VBD
ATII	NN
and	CC
the	DT
fibroblast	NN
to	TO
myofibroblast	NN
transition	NN
,	,
with	IN
greater	JJR
effects	NNS
than	IN
the	DT
sum	NN
of	IN
those	DT
obtained	VBN
using	VBG
JAK2	NN
or	CC
STAT3	NN
inhibitors	NNS
individually	RB
.	.

Dual	JJ
rather	RB
than	IN
single	JJ
inhibition	NN
was	VBD
also	RB
more	RBR
effective	JJ
for	IN
inhibiting	VBG
fibroblast	NN
migration	NN
,	,
preventing	VBG
increases	NNS
in	IN
fibroblast	NN
senescence	NN
and	CC
Bcl-2	NN
expression	NN
,	,
and	CC
ameliorating	VBG
impaired	JJ
autophagy	NN
.	.

In	IN
rats	NNS
administered	VBN
JSI-124	NN
,	,
a	DT
dual	JJ
inhibitor	NN
of	IN
p-JAK2	NN
/	:
p-STAT3	NN
,	,
at	IN
a	DT
dose	NN
of	IN
1	CD
mg/kg/day	NN
,	,
bleomycin-induced	JJ
lung	NN
fibrosis	NN
was	VBD
reduced	VBN
and	CC
collagen	NN
deposition	NN
in	IN
the	DT
lung	NN
was	VBD
inhibited	VBN
,	,
as	IN
were	VBD
JAK2	NN
and	CC
STAT3	NN
activation	NN
and	CC
several	JJ
markers	NNS
of	IN
fibrosis	NN
,	,
autophagy	NN
,	,
senescence	NN
,	,
and	CC
anti-apoptosis	JJ
.	.

CONCLUSIONS	NNS
:	:
JAK2	NN
and	CC
STAT3	NN
are	VBP
activated	VBN
in	IN
IPF	NN
,	,
and	CC
their	PRP$
dual	JJ
inhibition	NN
may	MD
be	VB
an	DT
attractive	JJ
strategy	NN
for	IN
treating	VBG
this	DT
disease	NN
.	.

